Impact of late presentation of HIV infection on short-, mid- and long-term mortality and causes of death in a multicenter national cohort: 2004-2013.

Sobrino-Vegas P, Moreno S, Rubio R, Viciana P, Bernardino JI, Blanco JR, Bernal E, Asensi V, Pulido F, Del Amo J, Hernando V, Cohorte de la Red de Investigación en Sida, Spain.

Journal Of Infection. 2016; 72: 587-596. FI: 4,201 (Q1).

Clinical characteristics, treatment and outcomes of MRSA bacteraemia in the elderly.

Cuervo G, Gasch O, Shaw E, Camoez M, Domínguez MÁ, Padilla B, Pintado V, Almirante B, Lepe JA, López-Medrano F, Ruiz de Gopegui E, Martínez JA, Montejo JM, Perez-Nadales E, Arnáiz A, Goenaga MÁ, Benito N, Horcajada JP, Rodríguez-Baño J, Pujol M, REIPI/GEIH study group.

Journal Of Infection. 2016; 72: 309-316. FI: 4,201 (Q1).

Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe.

Hofstra LM, Sauvageot N, Albert J, Alexiev I, Garcia F, Struck D, Van de Vijver DA, Åsjö B, Beshkov D, Coughlan S, Descamps D, Griskevicius A, Hamouda O, Horban A, Van Kasteren M, Kolupajeva T, Kostrikis LG, Liitsola K, Linka M, Mor O, Nielsen C, Otelea D, Paraskevis D, Paredes R, Poljak M, Puchhammer-Stöckl E, Sönnerborg A, Staneková D, Stanojevic M, Van Laethem K, Zazzi M, Zidovec Lepej S, Boucher CA, Schmit JC, Wensing AM, SPREAD Program.

Clinical Infectious Diseases. 2016; 62: 655-663. FI: 8,216 (Q1).

Short- versus long-duration levofloxacin plus rifampicin for acute staphylococcal prosthetic joint infection managed with implant retention: a randomised clinical trial.

Lora-Tamayo J, Euba G, Cobo J, Horcajada JP, Soriano A, Sandoval E, Pigrau C, Benito N, Falgueras L, Palomino J, Del Toro MD, Jover-Sáenz A, Iribarren JA, Sánchez-Somolinos M, Ramos A, Fernández-Sampedro M, Riera M, Baraia-Etxaburu JM, Ariza J, Prosthetic Joint Infection Group of the Spanish Network for Research in Infectio.

International Journal Of Antimicrobial Agents. 2016; 48: 310-316. FI: 4,307 (Q1).

Clinical outcomes of patients infected with HIV through use of injected drugs compared to patients infected through sexual transmission: late presentation, delayed anti-retroviral treatment and higher mortality.

Suárez-García I, Sobrino-Vegas P, Dalmau D, Rubio R, Iribarren JA, Blanco JR, Gutierrez F, Montero Alonso M, Bernal E, Vinuesa García D, Del Amo J, Cohort of the Spanish HIV Research Network (CoRIS).

Addiction. 2016; 111: 1235-1245. FI: 5,789 (Q1).

Endocarditis in patients with ascending aortic prosthetic graft: a case series from a national multicentre registry.

Ramos A, García-Montero C, Moreno A, Muñoz P, Ruiz-Morales J, Sánchez-Espín G, Porras C, Sousa D, Castelo L, Del Carmen Fariñas M, Gutiérrez F, Reguera JM, Plata A, Bouza E, Antorrena I, de Alarcón A, Pericás JM, Gurguí M, Rodríguez-Abella H, Ángel Goenaga M, Antonio Oteo J, García-Pavía P.

European Journal Of Cardio-Thoracic Surgery. 2016; 50: 1149-1157. FI: 3,759 (Q1).

Infective endocarditis: Absence of microbiological diagnosis is an independent predictor of inhospital mortality.

Díez-Villanueva P, Muñoz P, Marín M, Bermejo J, de Alarcón González A, Fariñas MC, Gutiérrez-Cuadra M, Pericás-Pulido JM, Lepe JA, Castelo L, Goenaga MÁ, Ruiz-Morales J, Tarabini P, Martínez-Sellés M, GAMES (Spanish Collaboration on Endocarditis — Grupos de Apoyo al Manejo de la E).

International Journal Of Cardiology. 2016; 220: 162-165. FI: 6,189 (Q1).

Effectiveness and safety of direct-acting antiviral therapies (DAA) in cirrhotic HCV monoinfected and HIV/HCV coinfected patient.

Carmona P, Von Wichmann MA, Arenas JI, Esandi F, Rodriguez-Arrondo F, Gayan MJ, Martin L, Iribarren JA.

Hepatology. 2016; 63: 991-991. FI: 13,246 (Q1).

2016 Expert consensus document on prevention, diagnosis and treatment of short-term peripheral venous catheter-related infections in adults.

Capdevila JA, Guembe M, Barberan J, de Alarcon A, Bouza E, Farinas MC, Galvez J, Goenaga, MA, Gutierrez F, Kestler M, Llinares P, Miro JM, Montejo M, Munoz P, Rodriguez-Creixems M, Sousa D, Cuenca J, Mestres CA, SEICAV Soc, SEMI Soc, SEQ Soc, SECTCV Soc.

Cirugia Cardiovascular. 2016; 23: 192-198.

Human immunodeficiency virus/hepatitis C virus coinfection in Spain: Prevalence and patient characteristics.

Berenguer J, Rivero A, Jarrín I, Núñez MJ, Vivancos MJ, Crespo M, Téllez MJ, Domingo P, Iribarren JA, Artero A, Márquez M, Santos I, Moreno J, Montero M, González-García J.

Open Forum Infectious Diseases. 2016; 3: -.

Characteristics and Outcome of Streptococcus pneumoniae Endocarditis in the XXI Century: A Systematic Review of 111 Cases (2000-2013).

de Egea V, Muñoz P, Valerio M, de Alarcón A, Lepe JA, Miró JM, Gálvez-Acebal J, García-Pavía P, Navas E, Goenaga MA, Fariñas MC, Vázquez EG, Marín M, Bouza E, GAMES Study Group.

Medicine (Baltimore). 2015; 94. FI: 5.723 (Q1).

Endocarditis due to Streptococcus tigurinus: presentation of a case and a review of the literature.

Michelena A, Bonavila C, Zubeltzu B, Goenaga MA.

Enferm. Infec. Microbiol. Clin. 2015; 33: 575-576. FI: 2.172 (Q3).

Características de los pacientes con infección por el virus de la inmunodeficiencia humana que no reciben tratamiento antirretroviral en España: estudio PICNIT.

Domingo P, Viciana P, Castaño M, Ferrer E.

Med. Clin. 2015; 144: 43-44. FI: 1.417 (Q2).

Virological failure to raltegravir in Spain: incidence, prevalence and clinical consequences.

Santos JR, Blanco JL, Masiá M, Gutiérrez F, Pérez-Elías MJ, Iribarren JA, Force L, Antela A, Knobel H, Salavert M, López Bernaldo De Quirós JC, Pino M, Paredes R, Clotet B, Integrase Resistance Study Group in Spain (INI-VAIN Study Group), Integrase Resistance Study Group in Spain INI-VAIN Study Group.

J Antimicrob Chemother. 2015; 70: 3087-3095. FI: 5.313 (Q1).